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ABSTRACT
Objective the composition of the healthy human 
adult gut microbiome is relatively stable over prolonged 
periods, and representatives of the most highly 
abundant and prevalent species have been cultured and 
described. However, microbial abundances can change 
on perturbations, such as antibiotics intake, enabling 
the identiication and characterisation of otherwise low 
abundant species.
Design analysing gut microbial time-series data, 
we used shotgun metagenomics to create strain level 
taxonomic and functional proiles. community dynamics 
were modelled postintervention with a focus on 
conditionally rare taxa and previously unknown bacteria.
Results in response to a commonly prescribed 
cephalosporin (ceftriaxone), we observe a strong 
compositional shift in one subject, in which a previously 
unknown species, UBorkfalki ceftriaxensis, was identiied, 
blooming to 92% relative abundance. the genome 
assembly reveals that this species (1) belongs to a so 
far undescribed order of Firmicutes, (2) is ubiquitously 
present at low abundances in at least one third of adults, 
(3) is opportunistically growing, being ecologically similar 
to typical probiotic species and (4) is stably associated 
to healthy hosts as determined by single nucleotide 
variation analysis. it was the irst coloniser after the 
antibiotic intervention that led to a long-lasting microbial 
community shift and likely permanent loss of nine 
commensals.
Conclusion the bloom of UB. ceftriaxensis and 
a subsequent one of Parabacteroides distasonis 
demonstrate the existence of monodominance 
community states in the gut. Our study points to an 
undiscovered wealth of low abundant but common 
taxa in the human gut and calls for more highly 
resolved longitudinal studies, in particular on ecosystem 
perturbations.
INTRODUCTION
The gut microbiota plays an important role in 
human health1 2 and is characterised by a diverse 
community and complex genetic variation land-
scape deducible from shotgun metagenomics 
data.3 Compared with the skin or oral cavity, GI 
microbiomes are remarkably stable over prolonged 
Significance of the study
What is already known on the subject?
 Ź Antibiotic treatments are known to reduce 
bacterial diversity short term, recovering usually 
within weeks.
 Ź Antibiotic-associated diarrhoea can be 
associated to blooms of pathogenic bacteria, 
like Clostridium difficile, although the cause is 
often also unknown.
 Ź Most abundant bacteria of the human gut 
microbiome are characterised and sequenced, 
but much less is known about the rare 
biosphere.
What are the new findings?
 Ź A member of an undiscovered order of 
Firmicutes that is prevalent in one-third of 
human gut samples, bloomed in multiple 
individuals after treatment with antibiotics. 
During blooming, it rose to 92% relative 
abundance, corresponding to a 2000-fold 
increase in absolute abundance.
 Ź The extreme bloom uncovers for the irst-time 
monodominant states in the adult gut by 
commensal bacteria. This was further reinforced 
by a second commensal, Parabacteroides 
distasonis, also becoming monodominant at 
95% relative abundance.
 Ź Nine commensal bacteria are absent in all time 
points after the extreme community reshaping, 
further conirmed using complete genome 
mappings.
 Ź A recurrent bacterial network response is 
observed after cephalosporin antibiotic 
treatment.
How might it impact on clinical practice in the 
foreseeable future?
 Ź This study highlights the detrimental impact of 
antibiotics on the adult gut microbiome, as well 
as shedding light on the recolonisation process, 
leading to ecosystem insights into antibiotic 
side effects.
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periods,4 which in particular applies to the more highly abun-
dant species.5 Much less attention has, however, been paid to 
low abundant species, despite having important keystone func-
tions in the human gut6 and explaining most of the temporal 
variation through conditionally rare taxa (CRT).7 The abun-
dance range is usually limited and extreme relative abundances 
exceeding 60% are only defined for forest ecosystems as mono-
dominance.8 Nonetheless, monodominance can be observed, for 
example, during the first days after birth in human gut micro-
biomes9 or in adults during infectious diarrhoea (typically asso-
ciated to Proteobacteria such as Vibrio cholera or Escherichia 
coli10). Frequently, however, the infectious source of diarrhoea 
remains unidentified,11 and little is known of the role of CRTs in 
the recolonisation of the gut microbiome after exogenous distur-
bances, such as antibiotic treatments.
This knowledge gap is compounded by CRTs often not 
being represented in genome collections12 or ill-defined. CRTs 
are often not detectable in metagenomes, because they are per 
definition rare and therefore difficult to spot with standard 
metagenomic approaches that rely on having either a reference 
genome in databases13 14 or sufficient read coverage in multiple 
samples to de novo construct metagenomic assembled genomes 
(MAGs).15 But even with reconstructed MAGs, insights on the 
ecological role of these novel species remain usually limited as 
the functional annotation of MAGs is often automatic.
To investigate microbial dynamics in response to antibi-
otic perturbations and the influence of CRTs, we leveraged an 
extensive longitudinal sampling and respective metagenome 
sequencing16 (see online supplementary file 1). We found that 
a novel bacterial species, UBorkfalki ceftriaxensis, which belongs 
to a new order of Firmicutes and bloomed during the first 3 days 
after antibiotic treatment to monodominant levels. UB. ceftriax-
ensis is thus the first report of a gut conditionally monodominant 
taxa (CMT) that is not invasive. Instead, it is globally prevalent 
in the population, but only associated to humans in our anal-
ysis of >3500 metagenomic samples. The initial colonisation by 
this species was succeeded by a second monodominant state by 
Parabacteroides distasonis. Of two antibiotics treatments, the first 
ceftriaxone treatment led to long-lasting community composi-
tion changes, including the apparent loss of nine species. Our 
study illustrates the wide range of abundance dynamics in the 
human gut microbiome and reveals that low abundant species 
can have important roles in community structuring.
RESULTS
UB. ceftriaxensis is a novel, common and low abundant human 
gut species
We used a metagenomic time series of one individual, HD.S1, 
sampled biannually over the course of 4 years, with a denser 
sampling around three interventions (two antibiotic treatments 
starting on day 370 and day 875 and a bowel cleansing event 
on day 630). Part of this time series was reported before16 and 
was extended by 10 samples to a total of 24 time points, with 
some samples being resequenced to greater depth or read length 
(see onlinesupplementary file 1). All samples were subjected to 
deep shotgun metagenomics (mean 68 million paired-end reads 
per sample). During the first intravenous antibiotics treatment 
on day 370, subject HD.S1 was hospitalised, receiving the 
third-generation cephalosporin, ceftriaxone. The sample from 
the day after the end of the antibiotic treatment (HD.S1.374, 
day 374) was excluded in previous analysis as it contained 
mostly reads that were not assignable to known species using 
standard approaches (e.g., mOTU or metaphlan13 14). Here, 
we performed de novo assembly of HD.S1.374 and metage-
nomic gene-level analysis, which both showed a single, hitherto 
unknown species, dominating this sample at 92% relative abun-
dance (online supplementary figure 1). Attempts to culture this 
species were not successful (see online supplementary tables 1 
and 2), but we were able to assemble the species genome with 
a quality comparable to assemblies from cultured species (see 
online supplementary tables 3 and 4). The conserved 16S rRNA 
JHQHVHTXHQFHZDVYHU\GLYHUJHQWQXFOHRWLGHQW LGHQ-
tity) to known bacteria (see the UB. ceftriaxensis belongs to a new 
order of Firmicutes section). Since the genome assembly is based 
solely on metagenomics, we named it UB. ceftriaxensis gen. nov., 
sp. nov., following the nomenclature proposed for uncultured 
species.17
Using fluorescence in situ hybridisation (FISH) (see online 
supplementary file 1), we could detect UB. ceftriaxensis in 
faecal samples (figure 1D), demonstrating that it was present in 
the stool. Labelled cells were rod shaped and on average 1.5 
(±0.3)×0.8 (± 0.1) µm long and wide (online supplementary 
table 5). Functional analysis of its gene content indicated that 
it is a facultative anaerobe spore-forming fermenter, with a 
large spectrum of monosaccharide and oligosaccharide utilisa-
tion genes (figure 1C, online supplementary figure 2 and table 
6 for a complete description). Its predicted fermentation prod-
ucts include two of the three short-chain fatty acids, acetate and 
propionate.
The discovery of UB. ceftriaxensis was enabled by its bloom 
after beta-lactam ceftriaxone treatment. We identified two genes 
distantly related to beta-lactamases, but in vitro tests showed 
only modest activity (see online supplementary file 1). Instead, 
it seems most likely that UB. ceftriaxensis is inherently resilient 
to ceftriaxone, due to its penicillin binding proteins of classes 
known to confer resistance in gram positive bacteria (see online 
supplement discussion) and due to its spore-forming ability.18 Its 
predicted diversified carbohydrate metabolism makes it plausible 
that UB. ceftriaxensis can grow extremely fast in an ecosystem 
devoid of competition.
To further explore this species global prevalence, we used 
the assembled genome as a bait to enable sensitive homology 
searches against 3692 public metagenomes (online supplemen-
tary table 7). We detected this species in most other samples 
from subject HD.S1, but also in 35% of adult human faecal 
samples (n=1558), as well as in 5% of samples from other body 
sites (n=972). Despite this wide prevalence, UB. ceftriaxensis 
was present at very low abundance (median 0.08%, max 0.7% 
relative abundance excluding samples from subject HD.S1, see 
online supplementary file 1 for additional details). It was further 
not detected in 1163 metagenomes balanced among ocean, soil 
and animal (mouse, pig, cat and dog) guts, strongly suggesting 
that UB. ceftriaxensis is a commensal specific to humans and 
mostly thrives in the gut microbiome, although at usually low 
abundances.
UB. ceftriaxensis is stably associated with its hosts
To investigate if UB. ceftriaxensis is a resident commensal of the 
healthy gut microbiome, we investigated if it is present over time 
in the same individual. Indeed, the species can be detected in 
multiple time points of the same individual (10 of 45 analysed 
individuals, online supplementary tables 7 and 8). In the 24 
time-series samples of subject HD.S1, it was detected in eight of 
these, spanning 1 year before and after the ceftriaxone treatment 
(online supplementary figure 1). Species level dynamics might be 
blurred by the influx of conspecific strains with different gene 
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content,19 as exchanges of dominant strains within a species have 
been reported in relation to external interventions.20 21 Yet, we 
hypothesised that the same strain of UB. ceftriaxensis was already 
a stable resident before the intervention, as subject HD.S1 did 
not report adverse effects after the antibiotic treatment and it 
seems more likely that the immune system would tolerate known 
commensals.22
To investigate strain dynamics, we reconstructed the UB. ceftri-
axensis genotype for 57 samples (37 individuals, including eight 
ZLWKWLPHSRLQWVWKDWKDG!ðJHQRPHFRYHUDJHDVORZHU
limit (mean 4.2× vertical and 71% horizontal genome coverage; 
online supplementary figure 3), using a novel single nucleotide 
variant (SNV) caller adapted for low abundant species (see online 
supplementary file 1). UB. ceftriaxensis had a clear population 
substructure, although being closely related: the mean between-
person genotype evolutionary similarity was 99.2%±0.34%, 
based on a recombination-corrected phylogeny23; therefore, all 
strains seem to belong to the same ecotype.24 This phylogeny 
Figure 1 Discovery and tracking of a novel bacterial species. (A) Composition plot (proportional abundance) of the 14 most abundant species in 
subject HD.S1 over the experiment duration. (B) The faecal microbial community of subject HD.S1 on days 374 and 377 after antibiotic treatment 
was characterised by extreme low diversity. The graphs show all genes (coverage >3) assembled from these sample with their guanine-cytosine (GC) 
content and coverage (online supplementary igures 16 and 17). Each sample is dominated by a single species and visible as denser gene clouds (38-
fold and 47-fold higher abundance then second most abundant species in those samples). The coloured dots represent the conserved marker genes29 
of ive species (colours as in A). The grey squares show 40 conserved marker genes of other species that are very low abundant. (C) Summary of 
functional potential of UBorkfalki ceftriaxensis based on genome assembly and functional annotation (see online supplementary ile 1). Short-chain 
fatty acids are indicated by yellow background. (D) UB. ceftriaxensis in faecal samples was detected via FISH, showing that it is viable within stool 
samples. It is a rod-shaped bacterium (white arrows, see online supplementary igure 15 for additional details). The tested sample was HD.S1.377. 
BMC, bacterial microcompartment, FISH, luorescence in situ hybridisation.
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showed that all strains without exception remain over time most 
similar within their specific host (figure 2, grey boxes), implying 
UB. ceftriaxensis is a stable part of the human microbiome. 
Furthermore, we found no evidence of multiple UB. ceftriaxensis 
strains colonising the same host (online supplementary figure 
S4C). However, some individuals carry very closely related 
strains. For example, genotypes of subjects HD.S7, ES.S1 and 
DK.S1 are on average only 185 nt distant from that of subject 
HD.S1 across the whole genome, suggesting the existence of a 
very recent progenitor of these strains. Nonetheless, even within 
this group, the genomes from single individuals can be clearly 
separated (figure 2).
UB. ceftriaxensis belongs to a new order of Firmicutes
To phylogenetically characterise UB. ceftriaxensis, we first anal-
ysed the 16S rRNA gene, the most widely used taxonomic marker. 
Empirical evidence suggests that 16S rRNA gene sequences are 
usually at least 95%, 92% and 89% conserved within the same 
genus, family and order, respectively.17 25 We confirmed that 
these thresholds apply to a set of 241 genomes representing all 
Firmicutes genera in the progenomes database,26 as well as four 
MAGs from human gut samples,15 that were selected for their 
similarity to UB. ceftriaxensis (online supplementary figure 5 and 
table 9). Our 16S rRNA gene analysis indicated that UB. ceftriax-
ensis represents a novel order, according to the above thresholds, 
as its nearest relative in the NCBI 16S database are the Firmicutes 
Christensenella massiliensis and Catabacter hongkongensis with 
86% 16S sequence identity (NCBI blast). We further confirmed 
this using orthogonal approaches: although RDP classifier27 
classifies the 16S rRNA to order Clostridiales at 100% confi-
dence, it is not assigned to lower levels at the recommended 80% 
confidence, the closest assignment being to family Catabacteria-
ceae (53% confidence). The Microbial Genomes Atlas analysis28 
indicated that this species represents a novel family or order 
(p=0.025, p=0.085, respectively). Our own within Firmicutes 
similarity-based analysis further confirmed its standing as a novel 
order (see online supplementary file 1).
To further investigate the phylogenetic placement of the new 
genome, we used the above set of 241 representative Firmicute 
genomes to construct maximum likelihood phylogenetic trees 
using either 40 conserved and universally present marker genes29 
(figure 3) or the 16S rRNA gene sequence (online supplementary 
figure 6). Although most families and classes are monophyletic 
in this tree, some taxa are polyphyletic or clearly misassigned, 
reflecting previously discussed problems with the conventional 
Firmicutes phylogeny.30 Consequently, we propose a number of 
changes to the current taxonomy, as well as a split of the currently 
polyphyletic Ruminococcaceae family, creating two new fami-
lies Erisaceae fam. nov. and Discordiaceae., fam. nov. (figure 3 
online supplementary table 10, supplementary discussion)
UB. ceftriaxensis is placed with high confidence into a clade 
together with three uncharacterised MGS, implying at least four 
distinct species, if not several genera (figure 3). They form a 
new family as the closest cultured relative to UB. ceftriaxensis, 
Catabacter hongkongensis, belongs to at least a separate family 
or order. Thus, to follow a standardised approach using empir-
ical sequence similarity thresholds for classifying higher order 
clades, we propose that UB. ceftriaxensis belongs to the novel 
family UComantemaea fam. nov. and the novel order UComan-
temales ord. nov.
UB. ceftriaxensis is a CMT
To get more insights into the ecology of UB. ceftriaxensis, we anal-
ysed the 4-year time series of subject HD.S1 (n=24). The ceftri-
axone intervention caused extreme perturbation of the species 
composition (figure 1A, online supplementary figure 7), leading 
to two successive monodominance community states immedi-
ately after treatment. In both cases, the monodominant species is 
likely represented by a single strain (estimated to have <10 devi-
ating fixed SNVs, online supplementary figure 4A,C). The first 
such state was identified 1 day after antibiotic treatment offset 
(day 374), with UB. ceftriaxensis representing 92% of all bacteria 
in this sample (corresponding to 2e11 cells/ml). This implies a 
7742-fold and approximately 2000-fold increase in relative and 
absolute abundance, respectively, compared with preantibiotic 
samples (online supplementary figure 8). After this initial bloom, 
UB. ceftriaxensis was still monodominant 2 days later (60.6%, 
day 376), but then rapidly decreased to its baseline level, close 
to the theoretical species detection level (online supplementary 
figure 1). As this bloom coincided with an extremely reduced 
community diversity and absolute cell counts were reduced by 
50% of the average (online supplementary figure 1), it appears 
Figure 2 UBorkfalki ceftriaxensis is found in multiple samples, but there is a clear substructure to the population. (A) Genotypes of UB. ceftriaxensis 
in 37 patients based on all genomic sites, using samples with ≥2× genome coverage. Genotypes are in all cases speciic to a subject where time series 
samples are available, with grey boxes indicating the same host. UB. ceftriaxensis type strain HDS1380 is marked by a white box. UB. ceftriaxensis 
shows large variation between individuals. The scale bar (5000 nt) corresponds to 0.2% genomic divergence.
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to be opportunistic blooming into an ecosystem conceivably 
lacking colonisation resistance.
The extremely deprived community found after the ceftri-
axone response was replaced with another monodominant 
community after only 3 days. This change was driven by the 
Bacteroidetes Parabacteroides distasonis (96.5% relative abun-
dance on day 377), increasing 60-fold and 74-fold (relative and 
absolute abundance, respectively) relative to preantibiotic states. 
It represented the lowest observed richness and diversity in the 
whole time series. The P. distasonis monodominance lasted for at 
least 3 days, with 87% and 62% relative abundance on days 378 
and 380, respectively, after which slow recovery was observed 
during the following weeks (online supplementary figure 9). P. 
distasonis was stable within the host HD.S1 during the whole 
observation period, represented by the same strain (online 
supplementary figure 10 for between individual analysis). 
Furthermore, the P. distasonis genome assembled from HD.S1 
was almost completely horizontally covered in HD.S1 samples 
(median 98%), but only at less than 80% in almost all samples 
from other individuals (n=104), even when the vertical coverage 
was far deeper than some HD.S1 samples (online supplementary 
figure 2). This demonstrates the P. distasonis HD.S1 assembly 
being of high quality, as well as subject specific.
To generalise and validate our findings, we investigated 
species dynamics using a recently published metagenomics 
dataset from patients treated with a cocktail of three broad spec-
trum antibiotics (meropenem, vancomycin and gentamicin).31 
Due to the dense sampling in this dataset we could replicate 
our results, by demonstrating a postantibiotic treatment mono-
dominance (>60% relative abundance) occurring in 7 of 12 
patients. Monodominant species varied, including P. distasonis 
as well as commensals such as Bacteroides vulgatus, Bifidobac-
terium longum, potential pathogens (Escherichia coli) and three 
species (206, 136 and 317) only identified in the mOTUs data-
base.13 In addition,UB. ceftriaxensis became more detectable after 
antibiotic treatment: it was detected in 5/12 and 11/12 patients 
Figure 3 Phylogenetic maximum likelihood tree of all Firmicutes genera in reference database, based on the AA sequence of 40 conserved genes. 
U
Borkfalki ceftriaxensis placement (red triangle) suggests that it represents a novel family, UComantemaea, as well as a new order, UComantemales, 
in phylum Firmicutes. Three uncharacterised putative species (MAGs) also belong to this family that were obtained by metagenomic binning before.15 
Only non-parametric bootstrap values >80/100 are shown (blue circles). Novel proposed Ruminococcaceae families are shown with arrows, to split 
this family into monophyletic groups. The outer ring colour shows family assignments of the remaining taxa in the tree. All monophyletic families are 
collapsed, while remaining families were either paraphyletic or the placement seemed not to it a monophyletic family origin. Further, species that 
group in conlict to current naming schemes are marked with purple triangles (online supplementary table 10). The tree is rooted with Escherichia coli 
, a gamma-proteobacterium. CAG, co-abundance group; IS, incertae sedis; MAG , metagenomic assembled genomes. 
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before and 4 days postantibiotic treatment, respectively. Notably, 
it was highly abundant in 3 of 12 patients, detected at 13, 7 
and 3.5% relative abundance in the latter samples. Its increase 
after non-beta-lactam antibiotics indicates a resistance extending 
beyond cephalosporine antibiotics, its likely presence at below 
detection thresholds in the healthy microbiome before antibiotic 
treatments in most patients and a general propensity to bloom 
into disturbed ecosystems.
To understand the impact of the apparent UB. ceftriaxensis 
resistance and monodominance along with the subsequent one 
of P. distasonis in our data set, we studied both short-term (<30 
days) and long-term (up to 1362 days, the end of the time series) 
community responses in HD.S1.
Short-term community response to ceftriaxone treatment
Of the three monitored interventions of subject HD.S1, the 
first, intravenous ceftriaxone treatment had the most severe 
effect on the microbiome. The microbial community was 
rebuilt from an almost barren ecosystem state to a complex, 
multispecies community. Two community rebuilding stages 
were observed, the first (days 374376) and second (days 
377380; 877881) response stages differing substantially in 
species compositions, dominant co-occurrence subnetworks 
and functional potential.
Rarefied species richness, diversity and evenness was reduced 
in postantibiotics samples (first and second stage, p=0.02, 
online supplementary figure 9) and the community was restruc-
tured at the class level: the first stage lead to an increase in Clos-
tridia, whereas the second stage is characterised by a Bacteroidia 
increase (online supplementary figure 11). To investigate species 
interactions, we constructed a species co-occurrence over the 
whole time series, specific to subject HD.S1 (figure 4A). The 
first stage, being driven by the Firmicute UB. ceftriaxensis, lasted 
2 days and was characterised by high abundance of a co-occur-
rence subnetwork that consisted mostly of typical small intestine 
and/or oral species (Streptococcus thermophilus, Lactobacillus 
casei, Propionibacterium freudenreichii, Veillonella sp., Rothia 
mucilaginosa and Lactobacillus rhamnosus) (figures 1A and 4A), 
most of which are typical lactose fermenters.32 In the second 
response stage, driven by P. distasonis, only few co-occurrences 
were observed, but instead co-exclusions to other species (n=17, 
figure 4A). After the intravenous ceftriaxone treatment, this 
second stage culminated in an extreme monodominance of P. 
distasonis. After an oral treatment with the second generation 
cephalosporin cefuroxime a year later (days 875881), P. dista-
sonis bloomed to 27% relative abundance and a similar co-ex-
clusion of species emerged (figure 4B). This recurrent similarity 
between community states after cephalosporin treatment was 
also revealed by multivariate analysis on the taxonomic compo-
sition (online supplementary figure 7).
We further hypothesised that the communitys functional 
potential differs between the two stages, especially for func-
tions related to resisting antibiotics (in form of antibiotic resis-
tance genes (ARGs)), to invade and establish themselves in new 
environments (putative pathogenicity/invasion genes (PPG)) 
as well as the dominant carbohydrate active enzyme (CAZy) 
repertoire, as carbohydrate metabolism is reported to facilitate 
microbial recovery (see the Discussion section). A multidimen-
sional analysis revealed a similar recurrent signal of the second 
stage response a year apart for CAZy, ARG and PPG compo-
sition (online supplementary figure 12). All three functional 
signatures varied significantly between stages, with the general 
pattern being an increase in CAZy and ARG potential in the 
second stage, while the first stage was enriched for PPG genes 
(figure 4C, online supplement result). CAZymes categories 
specific to food-derived (plants, animals) carbohydrates were 
increased during both second stages, especially after cefuroxime 
treatment, in contrast to decreased CAZYmes specific to micro-
bial substrates (bacterial, fungal) (online supplementary figure 
13), which could be interpreted as higher trophic levels being 
decreased during initial community rebuilding.
Long-term ecosystem changes after antibiotic treatment
Monodominance is likely a fragile state of adult gut microbiomes, 
as lower diversity is generally associated with decreased resilience 
in most ecosystems.33 Further disruptions might lead to detri-
mental ecosystem changes34 including catastrophic regime shifts. 
While we did not observe a catastrophic regime shift, we could 
detect long-lasting changes after ceftriaxone treatment, comprising 
an apparent loss of nine species and a shift in species dominance 
patterns in subject HD.S1. We discovered a strong species turn-
over after ceftriaxone treatment (figure 5A), indicating an almost 
complete replacement of species in adjacent time points. Intrigu-
ingly, Betaproteobacteria were almost undetectable after the initial 
antibiotic treatment and for the remainder of the time series, 
although often being associated with diarrhoea associated blooms 
following antibiotics.10 The Bacteroidetes P. distasonis was the only 
taxon significantly increased in relative abundance after the ceftri-
axone treatment in all subsequent time points (p=0.009, mean 
relative abundance 1.3%±0.3% pretreatment vs 20%±28%, 
online supplementary figure 1). In contrast, 26 species were signifi-
cantly decreased in relative abundance (online supplementary table 
11 and figure 14). Of these, 10 species could only be detected in 
all four samples before ceftriaxone treatment, but in none of the 20 
samples afterwards. To investigate species losses more specifically, 
we traced the 41 species consistently present in all preantibiotic 
samples: this analysis showed that 75% were still present in subject 
HD.S1 and in some post-ceftriaxone samples. However, 10 species 
could no longer be detected (figure 5B). This pattern is highly 
unlikely to occur by random chance: in 100 000 reshuffled time 
labels, this never occurred for several species, and even one species 
loss only happened in 0.094% of the reshuffled trials.
Because it is difficult to differentiate complete loss of a 
species from depletion to very low abundance, we calculated 
for these 10 species the observed horizontal genome coverage 
(O
cov
), filtering for O
cov
 consistent with expected coverage 
(see online supplementary file 1). Validating our marker-gene 
based approach, the median O
cov
 before ceftriaxone was 79% 
(figure 5C). Detecting even genomic fragments of these species 
was difficult in post-ceftriaxone samples: four species could 
not be detected at all after day 374 and O
cov
 was extremely 
low among the remaining six species (0.6% median). Only 
Eubacterium ramulus was detected at >10% O
cov
 at the last 
sampling point, 2.7 years after the initial antibiotic treatment 
and SNV analysis indicates this being the same strain; thus 
nine species appear to be lost to this ecosystem. Interestingly, 
there was a consistent low O
cov
 for four species on the day after 
antibiotic treatment (day 374) that could either be washout of 
dead cells or indicate that these species lack essential symbiotic 
species35 and could therefore no longer maintain themselves 
after community restructuring. Following the second antibiotic 
treatment, there was a consistent drop in O
cov
 among detected 
species as well as species detected via marker genes (figure 5B, 
C), suggesting that the same species suffer from cephalosporin 
treatments deterministically, having not attained an effective 
resistance mechanism.
 o
n
 7 February 2019 by guest. Protected by copyright.
http://gut.bmj.com/
G
ut: first published as 10.1136/gutjnl-2018-317715 on 18 January 2019. Downloaded from 
7Hildebrand F, et al. Gut 2019;0:1–10. doi:10.1136/gutjnl-2018-317715
Gut microbiota
Together, it appears that a regime shift36 occurred after the 
ceftriaxone treatment, with key indicators of an altered gut 
community being the considerable, long-lasting increase of P. 
distasonis relative abundance as well as the likely loss of several 
species.
DISCUSSION
We have identified a novel, endogenous, conditionally mono-
dominant taxon (CMT) in the human gut microbiome, UB. ceftri-
axensis, which is associated with the human host over long time 
periods. It is prevalent in one-third of public gut samples, but 
Figure 4 Microbial responses to antibiotics are relected in their co-occurrences. (A) Patient-speciic (subject HD.S1) species association network 
for 24 time points. The two monodominant species, UBorkfalki ceftriaxensis and Parabacteroides distasonis, are highlighted with their association 
networks. These networks differed substantially: UB. ceftriaxensis was positively correlated to typical probiotic, lactose-fermenting bacteria. P. 
distasonis had only few positive correlations, with most associations being negative (18 associations), which could suggest a competitive or 
opportunistic role. These two interaction networks represent taxa associated to the irst and second response stage, see (B). Nodes are coloured by 
their taxonomic class. Most associations are coloured grey, except those of UB. ceftriaxensis and P. distasonis, and only node names with associations 
to these are shown. Association line width and colour corresponds to Spearman correlations. Node size corresponds to average abundance of taxa in 
all HD.S1 samples. (B) The cumulative abundance of positive (above 0) and negative (below 0) taxa identiied as part of the irst and second response 
stage shows the dynamics of these subnetworks over time, coinciding with both antibiotic treatments. (C) Functional potential strongly varies 
between ecosystem successions (online supplementary tables 12 and 13). Carbohydrate active enzymes (CAZy) were enriched in the second response. 
Putative pathogenicity genes (PPG) were signiicantly increased in the irst and signiicantly reduced during seconda response , while for antibiotic 
resistance genes (ARG) the opposite was true. CAZy, PPG and ARG are scaled by max/min abundance in HD.S1.
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in general low abundant. Its discovery was enabled through its 
high abundance in postantibiotic stool samples and subsequent, 
reference-free genome binning. Additional mate-pair sequencing 
allowed the reconstruction of a high-quality genome from 
metagenomics data, as all culturing attempts were unsuccessful. 
Phylogenetically, it belongs to the phylum Firmicutes and class 
Clostridia, being the first representative of UComantemales, ord. 
nov.
UB. ceftriaxensis and P. distasonis were driving two observed 
monodominance community states that peaked at 92% and 
95% relative abundance, respectively. These states could be 
common in the gut, given that during their lifetime, many 
individuals are frequently subjected to gut microbiome pertur-
bations resulting, for example, from medication, disease or 
short-term digestion disturbances. Such monodominances could 
have remained unnoticed so far, either due to technical issues 
(discussed in the online supplementary file 1) or because they 
did not exhibit phenotypic effects during monodominant phases, 
like subject HD.S1. Antibiotic interventions are often, but not 
consistently, reported to decrease gut microbial diversity during 
and after treatments, followed by a recovery of the microbial 
community within weeks37 or months.38 The intravenous antibi-
otic treatment of HD.S1 shifted the postantibiotic microbiome 
composition significantly: several species appeared to have been 
simultaneously lost after treatment, compared with none at any 
other time point. Our simulations imply that such a non-detec-
tion over 20 time points and 1392 days due to random abundance 
fluctuations is highly unlikely. The loss of species after antibiotic 
treatments has only been reported recently on much shorter time 
scales and using only marker genes.31 Importantly, such shifted 
communities might induce long-term consequences that are not 
immediately noticeable like weight change,1 diabetic39 or maybe 
even Parkinsons disease predisposition.40
Short-term monodominant states can be essential parts of 
successions36 towards the restoration of a complex ecosystems.41 
Here, through hysteresis,42 UB. ceftriaxensis could have changed 
the community type in the longterm to what appears to be a 
healthy, but shifted, community state. For example, although 
no probiotics were consumed, most species co-occurring with 
UB. ceftriaxensis were probiotic species, frequently used to treat 
antibiotic associated diarrhoea (AAD).43 44 In an independent 
cohort,31 we discovered its enrichment following antibiotics 
treatments. This shows the potential importance of UB. ceftri-
axensis as a keystone species in rebuilding the gut community 
and as a probiotic candidate in future studies. The metabolism 
of UB. ceftriaxensis fits to this role, putatively fermenting a wide 
spectrum of simple carbohydrate sources to multiple short-chain 
fatty acids (figure 1C) that may suppress AAD.45 46
Figure 5 Species loss after ceftriaxone treatment in subject HD.S1. (A) Comparing components of community variation between time ordered 
samples revealed a strong community turnover followed by a peak in species loss/gain (ie, nestedness) after ceftriaxone treatment. We hypothesised 
that this led to permanent loss of certain species in patient HD.S1. (B) Forty-one species could be detected in all four preantibiotic time points, but 10 
of these were absent from postantibiotic samples. (C) We further tested the presence of these 10 species with a more targeted approach, mapping 
metagenomic reads against their reference genomes. Mappings were iltered to include only a ratio of expected (E
cov
) and observed (O
cov
) horizontal 
coverage between 0.5 and 2. The occurrence is noted in the lower part of the plot, marking the irst detection of a species with an upward triangle 
and the last observation with a downward triangle. The analysis shows that most species were present at high horizontal coverage before the 
intervention and generally not observed after the intervention, or with such a low horizontal coverage that observation of their marker genes was 
statistically unlikely, that is, they are not detectable by marker based approaches. The second antibiotic treatment seems to reduce the surviving 
species from the initial set. Note that the range of <10% genome coverage could as well represent mobile elements or highly conserved genes being 
preserved in other species and is therefore the threshold applied to conirm species detection.
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P. distasonis, the main driver of the second postantibiotics 
response stage, has been associated to faster microbiome recovery 
after antibiotic interventions.46 Bioavailable carbohydrates 
are important in the microbial recovery process45 46 and the 
second response stage was increased in total carbohydrate active 
enzymes (figure 5C). This type of community is also observed 
after another antibiotic treatment 1 year later and appears to be 
part of a semi-deterministic community response to antibiotics. 
Although earlier studies indicated that the microbial antibi-
otic response differs between individuals,37 studies with larger 
cohorts found that groups of patients can have similar recovery 
patterns, dependent on the initial composition.46 47 Therefore, 
the characterisation of the personal microbial antibiotic response 
should be an important goal of personalised medicine to enable 
a guided therapy. This might significantly increase effectiveness 
of treatments, prevent AAD and avoid the negative long-term 
consequences of species loss in the microbiome.
In summary, our analysis revealed a by-far underestimated 
dynamic nature of the human gut microbiome through the 
successive, extreme blooming of two commensal species after 
antibiotics treatment. The fast community restructuring allowed 
the characterisation of an otherwise low abundant species. 
Short-interval sampling after perturbations of the gut micro-
biome would further elucidate the role of conditionally mono-
dominant gut species, such as UB. ceftriaxensis, in resilience to 
perturbations, with prospective usage as indicators for disturbed 
microbial states.
Description of novel taxa
Description of Erisaceae fam. nov
Gr. fem. Noun, derived from Gr. Eris, Greek Goddess of discord 
and strife, since Ruminococcaceae family is phylogenetically 
separated by this taxon. Formerly of family Ruminococcaceae, 
it includes genera Ruminiclostridium, Acetivibrio, Pseudobacte-
roides and Clostridium and the following species: Clostridium 
cellulyticum, Clostridium josui, Pseudobacteroides cellulosol-
vens, Ruminiclostridium thermocellum and Acetivibrio cellulyt-
icus. This nomenclature is supported by maximum likelihood 
phylogeny based on 40 conserved universal marker genes as well 
as 16S analysis.
Description of Discordiaceae fam. nov
M.L. fem. Noun, derived from Lt. Discordia, Latin goddess of 
discord, since Ruminococcaceae family is phylogenetically separated 
by this taxon. The family contains one named genus, Maegeeiba-
cillus, and one named species, Maegeeibacillus indolicus, supported 
by maximum likelihood phylogeny based on 40 conserved universal 
marker genes as well as 16S analysis. Further, it may contain two 
species of uncertain taxonomic origin: Ruminococcaceae bacterium 
AB4001 and Ruminococcaceae bacterium AE2021 that fall within 
this family based on 40 conserved universal marker gene, but this is 
not supported by 16S analysis.
Description of UComantemales ord. nov
Comatemales (Co. mƗ n. te. ma. les. N.L. verb comantem, meaning 
blooming.). The order is represented by four genomes, UB. ceftri-
axensis, CAG727, CAG314 and CAG349, all of which are 
metagenomically assembled genomes without a cultured repre-
sentative, but are available in public databases. The closest rela-
tive is Catabacter hongkongensis, which based on 16S rRNA 
gene similarity is of a different order.
Description of UComantemaea fam. nov
Comatemaea (Co.mƗ n. te. maea. N.L. verb comantem, meaning 
blooming.). The family is represented by four genomes, UB. 
ceftriaxensis, CAG727, CAG314 and CAG349, all of which 
are metagenomically assembled genome without a cultured 
sample but are available in public databases.
Description of UBorkfalki gen. nov
 Borkfalki (Bork.fƗlk.í. (abbreviation) acknowledging the persons 
where the type strain was first described. The guanine-cytosine 
content of the genome of the type strain HDS1380 is 51.7%. 
The type species is UB.ceftriaxensis, which is a member of order 
Clostridiales, phylum Firmicutes, according to 16S rRNA gene 
analysis as well as analysis of 40 phylogenetically conserved 
marker genes.
Description of UB. ceftriaxensis sp. nov
UB. ceftriaxensis ( cef. tri. a. xen. sis. N.L. Arbitrary name. N.L. fem. 
adj. ceftriax- (abbreviation), ceftriaxone, the antibiotic on which 
proliferation of this species was observed; N.L. (abbreviation) 
fem. noun ensis, derived from Gr. Nemesis, Greek goddess of 
retribution, as in antagonist). The bacterium is rod shaped and 
1.5×0.8 µm in dimension. It is associated with the human micro-
biome, preferentially gut, but was so far not detected in other 
environments (animal guts, environmental samples). Bioinformatic 
annotation indicates that it is spore-forming anaerobe with fermen-
tative metabolism. It can metabolise a wide range of mono and 
oligosaccharides (see online supplementary methods). Likely meta-
bolic products include ethanol, lactate and acetate. Considering the 
genomic context, it is likely that it metabolises 1,2 propanediol to 
propanol and propionate, although the gene coding for the enzyme 
to produce the latter was not annotated. It can likely metabolise a 
wide range of monosaccharides and disaccharides (alpha-L-fuco-
side, alpha-L-rhamnoside, alpha-trehalose, beta-glucoside, cello-
biose, fructan, galactoside, L-arabinose, maltose, mannosides and 
mannose, sucrose and xylan). The type strains genome, HDS1380, 
was obtained from the metagenome of a patient being recently 
treated with the antibiotic ceftriaxone.
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